- Home
- FMX vs SYK Comparison
FMX vs SYK Comparison
Compare FMX & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMX
- SYK
- Stock Information
- Founded
- FMX 1890
- SYK 1941
- Country
- FMX Mexico
- SYK United States
- Employees
- FMX N/A
- SYK N/A
- Industry
- FMX Beverages (Production/Distribution)
- SYK Medical/Dental Instruments
- Sector
- FMX Consumer Staples
- SYK Health Care
- Exchange
- FMX Nasdaq
- SYK Nasdaq
- Market Cap
- FMX 148.0B
- SYK 144.9B
- IPO Year
- FMX 1998
- SYK N/A
- Fundamental
- Price
- FMX $90.37
- SYK $388.75
- Analyst Decision
- FMX Buy
- SYK Buy
- Analyst Count
- FMX 7
- SYK 18
- Target Price
- FMX $103.80
- SYK $429.00
- AVG Volume (30 Days)
- FMX 1.1M
- SYK 1.1M
- Earning Date
- FMX 10-27-2025
- SYK 10-28-2025
- Dividend Yield
- FMX 5.62%
- SYK 0.86%
- EPS Growth
- FMX N/A
- SYK N/A
- EPS
- FMX 0.30
- SYK 7.55
- Revenue
- FMX $43,105,359,505.00
- SYK $23,818,000,000.00
- Revenue This Year
- FMX $13.21
- SYK $11.73
- Revenue Next Year
- FMX $9.10
- SYK $8.51
- P/E Ratio
- FMX $27.26
- SYK $51.49
- Revenue Growth
- FMX 9.84
- SYK 11.36
- 52 Week Low
- FMX $81.08
- SYK $329.16
- 52 Week High
- FMX $108.74
- SYK $406.19
- Technical
- Relative Strength Index (RSI)
- FMX 57.41
- SYK 49.87
- Support Level
- FMX $84.67
- SYK $381.51
- Resistance Level
- FMX $87.89
- SYK $395.90
- Average True Range (ATR)
- FMX 2.02
- SYK 6.53
- MACD
- FMX 0.71
- SYK -0.28
- Stochastic Oscillator
- FMX 97.91
- SYK 47.13
About FMX Fomento Economico Mexicano S.A.B. de C.V.
Mexico-based Femsa is a beverage and retail conglomerate in Central and South America. The holding company owns controlling stakes in bottler Coca-Cola Femsa (47% economic stake, 56% voting rights), in addition to operating 100%-owned retail assets, including convenience stores under the Oxxo banner, drugstores, and gas stations. The firm divested its 15% stake in Heineken and its distribution business in 2023. Coca-Cola Femsa and the Oxxo chain made up 75% of total company revenue and over 90% of profits in 2024.
About SYK Stryker Corporation
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.